Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Bullboard Posts
Comment by 1stockwatcheron May 27, 2019 2:38pm
84 Views
Post# 29775844

RE:Wait & see game is getting old

RE:Wait & see game is getting old I agree with you.  I'm not sure what you deem substantial, all I can say is that I'm overweight in MDX based on it's performance at this point in time.  I think I will need to re-evaluate at the end of the year to decide how much I should continue to hold.

Things I need to see in 2019 to continnue to hold a significant number of shares.
1) Regulatory clearance from Brazil's version of the FDA for derm secure plus an agreement to purchase a minimal number of devices- resulting in cash going to Med X
2) Regulatory clearance for Mexico
3) Revenue from the Netherlands program
4) Revenue from the Spanish program
5) Revenue (not just an agreement or pilot) from a Canadian or American partner/customer

DermSecure was announced (Not sure we can say launched in September 2018) Anything less that that would be a disappointment. 
Bullboard Posts